Daito Pharmaceutical Co. Ltd. | Ownership
Companies that own Daito Pharmaceutical Co. Ltd.
Sumitomo Mitsui Asset Management Co., Ltd.
641,300
5.12%
641,300
0.11%
04/30/2018
Kuwait Investment Authority (Investment Management)
390,700
3.12%
272,780
0.07%
11/30/2017
The Vanguard Group, Inc.
238,300
1.9%
-100
0%
07/31/2018
Nomura Asset Management Co., Ltd.
198,099
1.58%
-95,000
0%
07/31/2018
Dimensional Fund Advisors LP
175,420
1.4%
2,800
0%
04/30/2018
Norges Bank Investment Management
160,570
1.28%
160,570
0%
11/30/2017
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.
147,000
1.17%
147,000
0.01%
07/31/2017
Daiwa Asset Management Co. Ltd.
105,299
0.84%
8,900
0%
07/31/2018
BlackRock Japan Co., Ltd.
91,500
0.73%
1,600
0%
06/11/2018
Nikko Asset Management Co., Ltd.
86,599
0.69%
499
0%
08/20/2018
| Address |
326 Yokamachi
Toyama Toyama 939
Japan
|
|
Employees
|
- |
| Website |
http://www.daitonet.co.jp |
| Updated |
07/08/2019 |
| Daito Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. It offers drug substances, prescription and over-the-counter drugs, home-delivery medicine, and health food. The company was founded on June 30, 1942 and is headquartered in Toyama, Japan. |
